Your browser doesn't support javascript.
loading
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.
Eyck, Ben M; van Lanschot, J Jan B; Hulshof, Maarten C C M; van der Wilk, Berend J; Shapiro, Joel; van Hagen, Pieter; van Berge Henegouwen, Mark I; Wijnhoven, Bas P L; van Laarhoven, Hanneke W M; Nieuwenhuijzen, Grard A P; Hospers, Geke A P; Bonenkamp, Johannes J; Cuesta, Miguel A; Blaisse, Reinoud J B; Busch, Olivier R; Creemers, Geert-Jan M; Punt, Cornelis J A; Plukker, John Th M; Verheul, Henk M W; Spillenaar Bilgen, Ernst J; van der Sangen, Maurice J C; Rozema, Tom; Ten Kate, Fiebo J W; Beukema, Jannet C; Piet, Anna H M; van Rij, Caroline M; Reinders, Janny G; Tilanus, Hugo W; Steyerberg, Ewout W; van der Gaast, Ate.
Afiliación
  • Eyck BM; Department of Surgery, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • van Lanschot JJB; Department of Surgery, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Hulshof MCCM; Formerly at Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • van der Wilk BJ; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Shapiro J; Department of Surgery, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • van Hagen P; Department of Surgery, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • van Berge Henegouwen MI; Department of Surgery, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Wijnhoven BPL; Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • van Laarhoven HWM; Department of Surgery, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Nieuwenhuijzen GAP; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Hospers GAP; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
  • Bonenkamp JJ; Comprehensive Cancer Center, University of Groningen-University Medical Center Groningen, Groningen, the Netherlands.
  • Cuesta MA; Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Blaisse RJB; Department of Surgery, Amsterdam University Medical Centers, Location VUmc, Amsterdam, the Netherlands.
  • Busch OR; Department of Medical Oncology, Rijnstate Hospital, Arnhem, the Netherlands.
  • Creemers GM; Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Punt CJA; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.
  • Plukker JTM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Verheul HMW; Formerly at Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Spillenaar Bilgen EJ; Department of Surgery, University of Groningen-University Medical Center Groningen, Groningen, the Netherlands.
  • van der Sangen MJC; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Rozema T; Formerly at Department of Medical Oncology, Amsterdam University Medical Centers, Location VUmc, Amsterdam, the Netherlands.
  • Ten Kate FJW; Department of Surgery, Rijnstate Hospital, Arnhem, the Netherlands.
  • Beukema JC; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands.
  • Piet AHM; Verbeeten Institute, Tilburg, the Netherlands.
  • van Rij CM; Formerly at Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Reinders JG; Formerly at Department of Pathology, Erasmus MC-University Medical Center Rotterdam, the Netherlands.
  • Tilanus HW; Department of Radiation Oncology, University of Groningen-University Medical Center Groningen, Groningen, the Netherlands.
  • Steyerberg EW; Department of Radiation Oncology, Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands.
  • van der Gaast A; Department of Radiation Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
J Clin Oncol ; 39(18): 1995-2004, 2021 06 20.
Article en En | MEDLINE | ID: mdl-33891478
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos